Enovix (NASDAQ:ENVX) Hits New 12-Month Low – What’s Next?

Enovix Corporation (NASDAQ:ENVX – Get Free Report) hit a new 52-week low on Wednesday. The company traded as low as $2.35 and last traded at $2.3850, with a volume of 12,335,264 shares. The stock had previously closed at $2.51.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ENVX shares. Bank of America reaffirmed a “neutral” rating and issued a $5.00 price objective on shares of Enovix in a research report on Monday, August 17th. Craig Hallum set a $7.00 target price on Enovix in a research report on Thursday, August 13th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a report on Friday, October 2nd. Canaccord Genuity Group lowered their price target on shares of Enovix from $15.00 to $10.00 and set a “buy” rating for the company in a report on Friday, August 14th. Finally, TD Cowen upgraded Enovix to a “hold” rating in a report on Monday, October 5th. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $10.77.

Read Our Latest Stock Report on Enovix

Enovix Stock Up 9.8%

The company has a market capitalization of $588.12 million, a PE ratio of -3.31 and a beta of 2.49. The company’s 50-day moving average is $3.22 and its 200 day moving average is $5.03. The company has a debt-to-equity ratio of 2.46, a quick ratio of 9.37 and a current ratio of 9.71.

Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The business had revenue of $9.02 million for the quarter, compared to analysts’ expectations of $8.43 million. During the same period in the prior year, the firm posted ($0.13) EPS. The firm’s quarterly revenue was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170–0.130 EPS. As a group, analysts anticipate that Enovix Corporation will post -0.79 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Sax Wealth Advisors LLC purchased a new stake in shares of Enovix in the 3rd quarter worth $29,000. Refined Wealth Management grew its holdings in shares of Enovix by 0.7% in the third quarter. Refined Wealth Management now owns 850,768 shares of the company’s stock valued at $2,467,000 after purchasing an additional 5,918 shares in the last quarter. Apella Capital LLC raised its position in shares of Enovix by 120.8% during the 3rd quarter. Apella Capital LLC now owns 60,540 shares of the company’s stock valued at $176,000 after buying an additional 33,120 shares in the last quarter. Sequoia Financial Advisors LLC bought a new stake in shares of Enovix in the 2nd quarter valued at approximately $61,000. Finally, Engineers Gate Manager LP boosted its stake in Enovix by 132.4% during the second quarter. Engineers Gate Manager LP now owns 51,281 shares of the company’s stock worth $311,000 after buying an additional 29,214 shares during the period. 50.92% of the stock is owned by hedge funds and other institutional investors.

About Enovix

(Get Free Report)

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company’s design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.

Featured Articles

Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.